Jeffrey La Rosa

Stock Analyst at Leerink Partners

(1.61)

# 2,296

Out of 4,497 analysts

2

Total ratings

100%

Success rate

11.28%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - General

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PYXS Pyxis Oncology	Initiates: Outperform	$12	$3.48	+244.83%	1	Jan 23, 2024
	MRK Merck & Co.	Maintains: Outperform	$110 → $112	$125.77	-10.95%	1	Oct 28, 2022

Pyxis Oncology

Jan 23, 2024

Initiates: Outperform

Price Target: $12

Current: $3.48

Upside: +244.83%

Merck & Co.

Oct 28, 2022

Maintains: Outperform

Price Target: $110 → $112

Current: $125.77

Upside: -10.95%